UBS analyst Joshua Spector raised the firm’s price target on Westlake (WLK) to $139 from $129 and keeps a Buy rating on the shares. The firm cites higher oil price assumptions and a tighter chemical market due to the Middle East conflict for the target boost. Near-term stock momentum is biased upward for the chemical names, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Westlake price target raised to $130 from $124 at Citi
- Warren Buffett’s (BRK.B) Final Deal to Buy Occidental Chemicals Looks Like a Genius Move
- Westlake upgraded to Outperform from Market Perform at BMO Capital
- Westlake price target raised to $120 from $100 at Alembic Global
- Westlake price target raised to $115 from $82 at BofA